SCHEMBL30598910

SCHEMBL30598910

CCNc1cc(C2(c3nncn3C)CC(C)C2)nc(Cl)n1

nearest known ligand 0.38

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
▸ CBLB Q13191 20/20 0.38
▸ CBL P22681 16/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25413303 1.00 CBLB (0.38) CBLBCBL
SCHEMBL30598901 0.84 — —
SCHEMBL25412295 0.84 — —
SCHEMBL25413553 0.83 CBLB (0.44) CBLBCBL
SCHEMBL25413551 0.83 CBLB (0.44) CBLBCBL
SCHEMBL25413016 0.71 CBLB (0.48) CBLBCBL
SCHEMBL25413018 0.71 CBLB (0.48) CBLBCBL
SCHEMBL25413065 0.70 HCAR3 (0.36) —
SCHEMBL25412703 0.69 CBLB (0.41) CBLBCBL
SCHEMBL25414247 0.68 HCAR3 (0.32) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4490152-A1 ACTIVATORS OF EFFECTOR T CELLS Orum Therapeutics Inc. (KR) 2025-01-15 — — EP disclosed
WO-2023170608-A1 ACTIVATORS OF EFFECTOR T CELLS ORUM THERAPEUTICS, INC. (KR) 2023-09-14 — — WO disclosed
Send feedback